Stay informed with the latest litigation news. Explore now

IP Verse

Elkington And Fife competitive analysis

Explore the latest publications and patents granted to Elkington And Fife, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Elkington And Fife against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3324956	Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 Receptor	ANAVEX LIFE SCIENCES	Jun 12, 2025
EP4014976	Aprocitentan For Use In The Treatment Of Hypertension And Related Diseases In Combination With Angiotensin Converting Enzyme Inhibitor (Ace) Or Angiotensin Receptor Blocker (Arb)	IDORSIA PHARMACEUTICALS	May 29, 2025
EP3815684	Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy	AMARIN PHARMACEUTICALS IRELAND	May 9, 2025
EP3799909	Nasal Delivery Devices	OPTINOSE	Apr 10, 2025
EP4005555	Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations	JANSSEN PHARMACEUTICA	Feb 14, 2025
EP4056176	Methods Of Reducing The Risk Of Cardiovascular Events In A Subject	AMARIN PHARMACEUTICALS IRELAND	Jan 24, 2025
EP3090730	Novel Pharmaceutical Composition	NOVARTIS	Jan 10, 2025
EP4175619	Compositions, Methods And Systems For Aerosol Drug Delivery	ASTRAZENECA PHARMACEUTICALS LP	Jan 9, 2025
EP4175620	Compositions, Methods And Systems For Aerosol Drug Delivery	ASTRAZENECA PHARMACEUTICALS LP	Jan 9, 2025
EP3150200	Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Jan 8, 2025

Discover the latest PTAB cases involving Elkington And Fife, highlighting their recent legal challenges and patent disputes.

Top competitors of Elkington And Fife based on patent oppositions.